Amy Kyle Cook & Henry H. Brownstein. (2017) Public Opinion and Public Policy: Heroin and Other Opioids. Criminal Justice Policy Review 30:8, pages 1163-1185.
Crossref
Julie Netherland & Helena Hansen. (2017) White opioids: Pharmaceutical race and the war on drugs that wasn’t. BioSocieties 12:2, pages 217-238.
Crossref
Travis Wendel, Geert Dhondt, Ric Curtis & Jay Hamilton. (2016) “More drugs, less crime”: why crime dropped in New York City, 1985–2007. Dialectical Anthropology 40:4, pages 319-339.
Crossref
Barry SpuntBarry Spunt. 2014. Heroin and Music in New York City. Heroin and Music in New York City
151
172
.
Barry SpuntBarry Spunt. 2014. Heroin and Music in New York City. Heroin and Music in New York City
103
126
.
. 2013. Addiction Trajectories. Addiction Trajectories
293
326
.
Emily Martin. 2013. Addiction Trajectories. Addiction Trajectories
284
292
.
A. Jamie Saris. 2013. Addiction Trajectories. Addiction Trajectories
263
283
.
Nancy D. Campbell. 2013. Addiction Trajectories. Addiction Trajectories
238
262
.
William Garriott. 2013. Addiction Trajectories. Addiction Trajectories
213
237
.
Eugene Raikhel. 2013. Addiction Trajectories. Addiction Trajectories
188
212
.
E. Summerson Carr. 2013. Addiction Trajectories. Addiction Trajectories
160
187
.
Anne M. Lovell. 2013. Addiction Trajectories. Addiction Trajectories
126
159
.
Helena Hansen. 2013. Addiction Trajectories. Addiction Trajectories
108
125
.
Todd Meyers. 2013. Addiction Trajectories. Addiction Trajectories
88
107
.
Natasha Dow Schüll. 2013. Addiction Trajectories. Addiction Trajectories
61
87
.
Angela Garcia. 2013. Addiction Trajectories. Addiction Trajectories
36
60
.
Eugene Raikhel & William Garriott. 2013. Addiction Trajectories. Addiction Trajectories
1
35
.
Honoria Guarino, Sarah K Moore, Lisa A Marsch & Sal Florio. (2012) The social production of substance abuse and HIV/HCV risk: an exploratory study of opioid-using immigrants from the former Soviet Union living in New York City. Substance Abuse Treatment, Prevention, and Policy 7:1.
Crossref
Helena Hansen & Samuel K. Roberts. 2012. Critical Perspectives on Addiction. Critical Perspectives on Addiction
79
102
.
Angela M. Robertson, Remedios Lozada, Robin A. Pollini, Gudelia Rangel & Victoria D. Ojeda. (2012) Correlates and Contexts of US Injection Drug Initiation Among Undocumented Mexican Migrant Men Who Were Deported from the United States. AIDS and Behavior 16:6, pages 1670-1680.
Crossref
Stella Blasel, Elke Hattingen, Michael Adelmann, Michael Nichtweiß, Friedhelm Zanella & Stefan Weidauer. (2010) Toxic Leukoencephalopathy after Heroin Abuse without Heroin Vapor InhalationToxische Leukoenzephalopathie nach nichtinhalativem Heroinabusus. MR-Bildgebung und klinischer Verlauf bei drei Patienten. Clinical Neuroradiology 20:1, pages 48-53.
Crossref
Alex Harocopos, Lloyd A. Goldsamt, Paul Kobrak, John J. Jost & Michael C. Clatts. (2009) New injectors and the social context of injection initiation. International Journal of Drug Policy 20:4, pages 317-323.
Crossref
Matthew T. Jordan, Sean M. Bryant, Steven E. Aks & Michael Wahl. (2009) A Five-Year Review of the Medical Outcome of Heroin Body Stuffers. The Journal of Emergency Medicine 36:3, pages 250-256.
Crossref
John C.M. Brust. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
314
328
.
Joanne E. Brady, Samuel R. Friedman, Hannah L. F. Cooper, Peter L. Flom, Barbara Tempalski & Karla Gostnell. (2008) Estimating the Prevalence of Injection Drug Users in the U.S. and in Large U.S. Metropolitan Areas from 1992 to 2002. Journal of Urban Health 85:3, pages 323-351.
Crossref
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
53
127
.
Kate McCoy, Judy McGuire, Ric CurtisBarry Spunt. (2016) White Chicks on Dope: Heroin and Identity Dynamics in New York in the 1990s. Journal of Drug Issues 35:4, pages 817-841.
Crossref
Joanne M. Kaufman, Dale D. Chitwood, Mary Comerford & Dixie Koo. (2016) Characteristics and Patterns of use among Regular Heroin Sniffers. Journal of Drug Issues 34:4, pages 805-830.
Crossref
Andrew Golub, Bruce D. Johnson, Eloise Dunlap & Stephen Sifaneck. (2016) Projecting and Monitoring the Life Course of the Marijuana/Blunts Generation. Journal of Drug Issues 34:2, pages 361-388.
Crossref
Daliah Heller, Kate McCoy & Chinazo Cunningham. (2016) An Invisible Barrier to Integrating HIV Primary Care with Harm Reduction Services: Philosophical Clashes between the Harm Reduction and Medical Models. Public Health Reports 119:1, pages 32-39.
Crossref
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
43
103
.
Alison Seymour, Marjorie Black, Jane Jay, Gail Cooper, Christopher Weir & John Oliver. (2003) The role of methadone in drug-related deaths in the west of Scotland. Addiction 98:7, pages 995-1002.
Crossref
María J. Bravo, Gregorio Barrio, Luis De La Fuente, Luis Royuela, Laura Domingo & Teresa Silva. (2003) Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction 98:6, pages 749-760.
Crossref
Jami L Rothenberg, Maria A Sullivan, Sarah H Church, Angela Seracini, Eric Collins, Herbert D Kleber & Edward V Nunes. (2002) Behavioral naltrexone therapy. Journal of Substance Abuse Treatment 23:4, pages 351-360.
Crossref
Lorna E. Thorpe, Susan L. Bailey, DeZheng Huo, Edgar R. Monterroso & Lawrence J. Ouellet. (2001) Injection-Related Risk Behaviors in Young Urban and Suburban Injection Drug Users in Chicago (1997–1999). JAIDS Journal of Acquired Immune Deficiency Syndromes 27:1, pages 71-78.
Crossref
Lorna E. Thorpe, Susan L. Bailey, DeZheng Huo, Edgar R. Monterroso & Lawrence J. Ouellet. (2001) Injection-Related Risk Behaviors in Young Urban and Suburban Injection Drug Users in Chicago (1997–1999). Journal of Acquired Immune Deficiency Syndromes 27:1, pages 71-78.
Crossref
Patrick G. O'ConnorDavid A. Fiellin. (2000) Pharmacologic Treatment of Heroin-Dependent Patients. Annals of Internal Medicine 133:1, pages 40.
Crossref
Ruben Olmedo & Robert S. Hoffman. (2000) WITHDRAWAL SYNDROMES. Emergency Medicine Clinics of North America 18:2, pages 273-288.
Crossref
Travis Wendel & Ric Curtis. (2000) The Heraldry of Heroin: “Dope Stamps” and the Dynamics of Drug Markets in New York City. Journal of Drug Issues 30:2, pages 225-259.
Crossref
Karamarie Fecho, Christina J Nelson & Donald T Lysle. (2000) Phenotypic and functional assessments of immune status in the rat spleen following acute heroin treatment. Immunopharmacology 46:3, pages 193-207.
Crossref
A.R. KriegsteinD.C. ShunguW.S. MillarB.A. ArmitageJ.C. BrustS. ChillrudJ. GoldmanT. Lynch. (1999) Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (“chasing the dragon”). Neurology 53:8, pages 1765-1765.
Crossref
Jo L. Sotheran, Douglas S. Goldsmith, Martín Blasco & Samuel R. Friedman. (1999) Heroin Sniffing as Self-Regulation among Injecting and Non-Injecting Heroin Users. Journal of Drug Issues 29:2, pages 401-421.
Crossref
Xavier Andrade, Stephen J. Sifaneck & Alan Neaigus. (1999) Dope Sniffers in New York City: An Ethnography of Heroin Markets and Patterns of Use. Journal of Drug Issues 29:2, pages 271-298.
Crossref